Trial intelligence / Profile preview

FOLFOX-A in Metastatic Pancreatic Cancer

NCT02080221Phase 2Completed

Sponsor
Brown University
Start
Aug 2014
Primary completion
Jan 2020
Countries
1
01

Overview

A Phase 2 trial of nab-paclitaxel in pancreatic ductal adenocarcinoma (PDAC), sponsored by Brown University. Started Aug 2014; status: completed.

02

Drugs

nab-paclitaxel
03

Conditions

pancreatic ductal adenocarcinoma (PDAC)

Beyond the preview

Go deeper on NCT02080221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02080221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call